Valuing Orthopedic Practices in 2026: A Comprehensive Guide for Physicians, Owners, Investors, and M&A Professionals

Orthopedic practices occupy a distinctive position in the healthcare valuation landscape. The specialty spans an unusually broad clinical and economic spectrum; from office-based evaluation and management visits and nonsurgical musculoskeletal care to high-acuity total joint arthroplasty, complex spinal surgery, and sports medicine procedures performed across multiple sites of service. This breadth of service mix, combined with heavy capital investment in implants, robotics, and ancillary infrastructure like ambulatory surgery centers (ASCs) and imaging, makes orthopedic practice valuation a fundamentally different exercise than valuing most other physician specialties.

Complicating matters further, the orthopedic umbrella encompasses numerous subspecialties (joint reconstruction, spine surgery, sports medicine, hand and upper extremity, foot and ankle, trauma, and pediatric orthopedics), each with distinct revenue profiles, reimbursement dynamics, and risk characteristics. A spine-heavy group with owned ASCs will look dramatically different from a sports medicine practice focused on arthroscopy and nonoperative care, even if top-line revenues are comparable. The site-of-service distribution, degree of ancillary capture, payer mix, and subspecialty composition all fundamentally alter value drivers and risk considerations.

This article provides a detailed overview of key valuation methodologies, drivers, and risk factors relevant to orthopedic practices in 2026. Whether you are a surgeon-owner exploring a private equity partnership, a health system evaluating an acquisition target, or an investor building an orthopedic platform, this guide offers the analytical framework and current market intelligence needed to approach an orthopedic valuation with confidence.

I. Industry Context: Why Orthopedic Practices are in Demand

Orthopedic practices remain among the most actively pursued targets in healthcare M&A. The specialty sits at the intersection of powerful demographic tailwinds, expanding procedural volumes, and a rapid shift toward lower-cost outpatient settings—a combination that continues to attract private equity capital, health system acquirers, and strategic consolidators.

Key Growth Drivers

• Aging Population and Rising Musculoskeletal Demand: The 65-and-older population is the fastest-growing demographic segment in the United States, and musculoskeletal conditions are among the most prevalent chronic diseases in this group. Total joint arthroplasty caseloads alone are projected to double by 2050, and age-related conditions including degenerative disc disease, osteoarthritis, rotator cuff pathology, and fragility fractures ensure sustained procedural volume growth for decades to come.

• Outpatient Migration and ASC Expansion: CMS continues to remove orthopedic procedures from the inpatient-only list, and the ASC covered procedure list now includes total hip and total knee arthroplasty, shoulder replacement, and a growing number of spine procedures. Nearly all hand, foot and ankle, and sports medicine arthroscopy now occurs in the ASC setting. This migration improves margins, shortens recovery times, and creates new ancillary revenue opportunities for practices that own or co-invest in ASC capacity.

• Technological Innovation and Robotics Adoption: Robotic-assisted surgery, AI-driven preoperative planning, 3D-printed patient-specific implants, and advanced navigation systems are becoming standard features of competitive orthopedic practices. The global orthopedic device market is projected to grow at a CAGR of 4.3%, from $60.4 billion in 2023 to $80.8 billion by 2030. Practices that adopt these technologies early can differentiate on outcomes and attract both patients and referring physicians.

• Obesity Epidemic and Active Lifestyle Trends: Rising adult obesity rates are increasing the incidence of weight-bearing joint degeneration, accelerating the need for joint replacement and related interventions at younger ages. Simultaneously, an increasingly active adult population is driving demand for sports medicine and arthroscopic services—ACL reconstruction, meniscal repair, and tendon surgery volumes are rising steadily, fueled in part by participation in recreational activities like pickleball, skiing, and adult recreational leagues.

Reimbursement Outlook

The 2026 Medicare Physician Fee Schedule brings a mixed picture for orthopedic surgeons. CMS increased the conversion factor to $33.40 for non-qualifying APM participants (up 3.26%) and $33.57 for qualifying APM participants (up 3.77%), reflecting the temporary 2.5% pay increase Congress passed through the One Big Beautiful Bill Act. However, CMS simultaneously finalized a -2.5% efficiency adjustment applied to the work RVUs of most non-time-based services—a provision that disproportionately impacts surgical specialties. One analysis estimates orthopedic surgery faces a -5% overall payment impact once the efficiency adjustment and practice expense changes are combined (Spry, RVU Updates 2026).

CMS also finalized a significant reduction in indirect practice expense RVUs for facility-based services. Physician payment for services delivered in hospitals and ASCs will drop approximately 7% overall, while office-based services see a roughly 5% increase, which is a meaningful headwind for orthopedic surgeons who perform a large share of procedures in facility settings (AMA, 2026 Medicare PFS Analysis). Additionally, CMS finalized a mandatory Ambulatory Specialty Model (ASM) beginning in 2027 that will require orthopedic surgeons treating Medicare beneficiaries with low back pain to participate in a two-sided risk arrangement with payment adjustments of up to 9–12% (Forvis Mazars, Key Updates on the 2026 Medicare PFS). Commercial payers increasingly reference Medicare benchmarks in their own fee schedules, meaning downward Medicare pressure often cascades into private contracts over time.

II. Top Reasons to Get a Valuation of Your Orthopedic Practice

The following is a list of common reasons for commissioning a valuation analysis or appraisal of a Orthopedic Practice:

1. Preparing for a Sale or Strategic Partnership

• To establish a defensible asking price when marketing the business

• To evaluate offers from private equity, strategic buyers, or joint venture partners

• To understand how your practice compares to market benchmarks

  
  

2. Internal Ownership Transition

• For buy-in or buy-out of partners or associates

• To support fair and compliant equity allocation among clinicians

• To plan for generational succession or family transfers

3. Compliance with Healthcare Regulations

• To support Fair Market Value (FMV) and Commercial Reasonableness (CR) assessments required by Stark Law and Anti-Kickback Statute in deals involving ownership by other healthcare providers

• To document compliance in joint ventures, especially when there is a referral relationships (hospitals, ancillary service providers, or physicians)

  
  

4. Estate & Tax Planning

• For gift or estate tax reporting to the IRS (especially for closely held businesses)

• To support asset protection strategies

• To plan for long-term wealth transfer or charitable contributions

  
  

5. Litigation or Dispute Resolution

• For divorce proceedings involving business asset division

• In shareholder or partnership disputes

• For economic damages assessments in legal proceedings

  
  

6. Business Planning & Strategic Growth

• To establish a valuation baseline for performance benchmarking

• To support capital raise, refinancing, or line-of-credit applications

• To identify value drivers and areas for operational improvement

III. Valuation Approaches for Orthopedic Practices

Valuation professionals typically apply three core methodologies to estimate the value of an orthopedic practice:

Income Approach (Discounted Cash Flow or Capitalization of Earnings)

This approach values a business based on the present value of its expected future earnings or cash flows. It’s most appropriate when a practice has a stable operating history and predictable future performance.

Key assumptions include:

• Normalized EBITDA or owner’s discretionary earnings

• Growth rate assumptions (organic and acquisitive)

• Risk-adjusted discount rate (typically 10–25% for orthopedics)

• Capital expenditure needs

Pros: Based on the business’ future earning power

Cons: Sensitive to forecasting errors and discount rate subjectivity

Market Approach (Comparable Transaction Method, e.g. Market Multiples)

This method uses observed EBITDA multiples or revenue multiples from recent M&A transactions or public companies in the orthopedics space.

Pros: Easy to benchmark; useful in active M&A environments

Cons: Requires access to quality private market data and careful adjustment for size, margin, geography, and a variety of other factors

Asset-Based Approach

Used only when the business is underperforming or being liquidated. The value is derived from the net assets (e.g., equipment, leasehold improvements) minus liabilities.

Pros: Useful in distressed scenarios

Cons: Intangible value of the practice can be difficult to quantify under this method

IV. Key Value Drivers in Orthopedic Practice's Valuation

Several specific factors can materially influence a orthopedic practice’s valuation multiple:

Earnings Quality

The foundation of any orthopedic practice valuation is normalized EBITDA or cash flow. Buyers and appraisers will scrutinize the practice's reported earnings and make adjustments to arrive at a sustainable, transferable earnings figure. Common normalization adjustments in orthopedic practices include:

• Owner Compensation: Surgeon-owner compensation is typically adjusted to reflect a market-rate salary for clinical services. In orthopedics, where total compensation often exceeds $500,000 per surgeon, the spread between actual and market-rate compensation can significantly affect normalized EBITDA.

• Non-Recurring Items: One-time costs such as litigation settlements, equipment purchases expensed rather than capitalized, or COVID-related revenue disruptions are excluded from normalized earnings.

• Related-Party Leases: Practices that lease office space, ASC facilities, or equipment from entities owned by the surgeon-owners will have these rents adjusted to fair market rates.

• Post-Transaction Adjustments: Costs that will be eliminated or restructured following a transaction—such as redundant administrative staff, overlapping insurance policies, or management fees—may be added back to arrive at pro forma earnings.

• Out-of-Period Adjustments: Revenue or expenses attributable to prior periods (e.g., retroactive payer settlements, delayed insurance collections) are removed to reflect the practice's true run-rate performance.

  
  

Growth Potential

• ASC Ownership and Site-of-Service Optimization: Practices that own or hold equity in an ASC capture facility fees, improve scheduling control, and benefit from the ongoing migration of orthopedic procedures to outpatient settings. CMS's continued expansion of the ASC covered procedure list—now including total joints, shoulder replacements, and select spine procedures—creates meaningful margin expansion opportunities for practices positioned to capture this volume internally rather than directing it to hospital partners.

• Ancillary Service Capture — Imaging, PT, and DME: Orthopedic practices that operate in-office MRI, CT, or X-ray, as well as affiliated physical therapy clinics and durable medical equipment (DME) dispensing, benefit from multiple revenue streams tied to the same patient episode. Ancillary capture typically adds 1 to 3 multiple turns to EBITDA valuations, and practices with strong internal referral conversion rates are viewed favorably by acquirers.

• Provider Recruitment and Capacity Expansion: The ability to recruit and retain orthopedic surgeons, sports medicine physicians, and advanced practice providers across multiple subspecialties creates scalable growth. Practices with a demonstrated track record of successful recruitment—particularly in high-demand subspecialties like joint replacement, spine, and sports medicine—command premium valuations because they reduce the buyer's execution risk on future growth.

  
  

Risk Factors

• Reimbursement Pressure and Medicare Dependence: Practices with a heavy Medicare payer mix face ongoing headwinds from the efficiency adjustment, site-of-service payment differential, and the upcoming mandatory ASM model. The cumulative effect of five consecutive years of Medicare conversion factor reductions prior to 2026—combined with the new efficiency adjustment that offsets much of the 2026 increase—creates real uncertainty about long-term Medicare reimbursement adequacy for surgical specialties. Buyers will discount practices with high government payer concentration accordingly.

• Provider Concentration and Key-Person Risk: Many orthopedic practices derive a disproportionate share of revenue from one or two high-producing surgeons, often the founding partners. If those surgeons are nearing retirement or have limited contractual commitments post-transaction, the practice's earnings durability is at risk. Acquirers will seek employment agreements, non-compete provisions, and retention incentives to mitigate key-person dependence, and practices that cannot demonstrate a deep, stable provider bench will face valuation discounts.

• Regulatory and Compliance Exposure: Orthopedic practices face a complex regulatory landscape that extends beyond standard billing compliance. Implant vendor relationships, physician-owned ASC and imaging center structures, and physician-industry financial arrangements all create potential exposure under the Stark Law, Anti-Kickback Statute, and state self-referral prohibitions. Practices without robust compliance programs, documented FMV opinions for ancillary arrangements, and clean billing histories present elevated risk to buyers.

  
  

V. Current Market Trends in Orthopedic M&A

Orthopedics remains an attractive specialty from an M&A perspective, although public M&A deal announcements fluctuate significantly from year to year, and represent only a small portion of actual deal volume.

Orthopedic EBITDA Multiple Trends

The orthopedic M&A market has matured significantly since private equity firms first began partnering with orthopedic practices in 2017. Today, more than 16 PE-backed management companies are actively consolidating the specialty. Larger orthopedic platforms (those with EBITDA exceeding $10 million, diversified subspecialty coverage, owned ASC capacity, and professional management) have historically commanded EBITDA multiples in the 10x to 14x range, with select transactions clearing even higher for platforms with exceptional growth profiles.

The scale premium in orthopedics is substantial. Private equity firms employ a two-tiered valuation model, acquiring smaller practices at lower multiples (typically 7x to 10x EBITDA) and consolidating them into larger networks where the combined platform may trade at 12x to 14x or more upon exit. This multiple arbitrage remains the fundamental economic engine of PE-backed orthopedic consolidation.

Cash Flow Multiples for Small Orthopedic Practices

There are a number of small orthopedic practices listed for sale at any given time, but it's difficult to glean much useful information from data on smaller businesses where context around the level of owner involvement is unavailable. An orthopedic practice making $500k per year in cash flow for an absentee owner is much different from an Orthopedic practice making $500k per year in take-home for a full-time owner-operator. Our study of current and recently removed businesses for sale shows a range of multiples from 1.72x cash flow to 3.6x cash flow at the 25th and 75th percentiles, with a median of 2.73x.

VI. Final Thoughts: Keys to Maximizing Value

If you're a orthopedic practice owner or executive planning to explore a sale or equity partnership, consider the following strategies to enhance your valuation:

1. Optimize and Internalize High-Margin Ancillary Services

Orthopedic practices that own or hold equity in ASCs, imaging centers (MRI, CT, X-ray), physical therapy clinics, and DME operations capture significantly more revenue per patient episode than those that refer externally. Evaluate whether your practice can bring currently outsourced ancillary services in-house or increase ownership in existing joint ventures. Each incremental dollar of high-margin ancillary revenue improves profitability and adds multiple turns to your EBITDA valuation.

2. Strengthen the Provider Platform and Reduce Key-Person Risk

A practice built around one or two star surgeons is inherently riskier (and therefore less valuable) than one with a deep, diversified provider bench. Invest in recruiting across multiple subspecialties (joint replacement, sports medicine, spine, hand, foot and ankle), develop a robust advanced practice provider (APP) program, and formalize mentorship pathways for junior surgeons. Ensuring that no single provider accounts for more than 25–30% of total collections dramatically reduces key-person discount in a valuation.

3. Improve Revenue Cycle Management and Contract Economics

Orthopedic practices lose significant revenue to undercoding, claim denials, and suboptimal payer contracts. Conduct a thorough payer contract review to identify commercial rates that have fallen below Medicare benchmarks, implement pre-authorization workflows to reduce denial rates on high-value surgical procedures, and invest in charge capture technology to ensure all billable services are captured appropriately. Clean, well-documented revenue cycle performance gives buyers confidence in the sustainability of reported earnings.

4. Expand Access, Footprint, and Referral Networks

Growth visibility is one of the most important drivers of valuation multiples. Develop a deliberate strategy for geographic expansion through satellite clinics in underserved markets. Cultivate referral relationships with primary care physicians, urgent care centers, sports medicine clinics, physical therapists, and athletic training programs at local high schools and universities. Practices with a diversified, growing referral pipeline command premium valuations.

5. Professionalize Operations and Financial Reporting

Buyers—particularly PE firms and health systems—expect auditable financial statements, documented policies and procedures, current compliance programs, and clean corporate governance. Invest in a qualified practice administrator or COO, implement monthly financial reporting with KPI dashboards, and maintain organized documentation of provider contracts, payer agreements, and lease arrangements. Practices that present "deal-ready" financials and operations move through due diligence faster and often achieve higher valuations because they reduce perceived execution risk.

About HealthFMV

HealthFMV specializes in appraising healthcare businesses and services arrangements, including orthopedics.

• Business Valuation: We perform independent, third-party valuations of healthcare businesses to document regulatory, tax, and financial reporting compliance, resolve ownership disputes, and help ensure both parties to the transaction are comfortable with the financial terms.

  
  

• Transaction Advisory: We work with healthcare business owners, organization executives, providers, and their health lawyers to develop transaction structures and deal terms that further their business objectives while maintaining compliance with the complex healthcare regulatory environment.

  
  

• Services Arrangements: We prepare fair market value and commercial reasonableness opinions for a variety of healthcare services arrangements including management services, hospital-based specialty stipends, case rates and PC/TC splits, block leasing, and shared savings distributions, among others.

Contact Will Hamilton at whamilton@healthfmv.com with questions about our healthcare valuation services or to discuss your specific situation. Visit scoperesearch.co for more information about our healthcare M&A research services.